Cold Laser Therapy Market

Cold Laser Therapy Market Snapshot (2023 to 2033)

The global market of Cold Laser Therapy is expected to enjoy a valuation of USD 117.1 million by the end of the year 2023, and further expand at a CAGR of 4.4% to reach a valuation of USD 180.8 million by the year 2033. According to a recent study by Future Market Insights, continuous laser devices are leading the market with an expected share of about 55.6% in the year 2023, within the global market.

Data Points	Market Insights
Market Value 2022	USD 112.4 million
Market Value 2023	USD 117.1 million
Market Value 2033	USD 180.8 million
CAGR 2023 to 2033	4.4%
Market Share of Top 5 Countries	57.9%
Key Market Players	Apira Science Inc., B-Cure laser Australia, Erchonia Corporation, Theralase Inc., DJO Global, Inc. (Colfax Corporation), BTL, BioLight Technologies LLC, THOR Photomedicine Ltd, Irradia, PhotoMedex, Lexington International, LLC, MICROLIGHT Corporation, and Apollo (Pivotal Health Care LLC)

A conservative treatment known as a non-invasive technique does not include making an incision in the body or removing tissue. One such treatment that is frequently used in the management of pain and the treatment of skin is laser or cold laser therapy.

For the therapeutic treatment of diseases, cool or low-level lasers are being used more frequently. It is mostly because of their non-intrusiveness. Non-invasive procedures include fewer to no side effects, no scars from cuts, and a shorter hospital stay.

In addition to pain relief and muscular relaxation, it also aids in wound healing. Hair removal and regrowth, cellulite reduction, scar reduction, and inflammatory skin conditions are just a few of the cosmetic procedures that involve cold laser therapy.

Sales Analysis of Cold Laser Therapy from 2016 to 2022 Vs Market Outlook for 2023 to 2033

The market value for cold laser therapy was approximately 11.3% of the overall ~USD 997 million of global light therapy market in 2022.

The sale of cold laser therapy expanded at a CAGR of 4.0% from 2016 to 2022, owing to rising awareness of cosmetic procedures globally.

In recent years, significant progress has been made in the understanding of the biology of wound healing. The proliferation, differentiation, migration, and adherence of several cell types are traits of wound healing. Additionally, a number of modulators, such as low-level laser therapy (LLLT), have gained widespread acceptance as adjuvant medical tools for the treatment of wounds.

The primary idea behind LLLT is the bio-stimulation effect which is centered on the notion that stimulation from a specific wavelength can alter cellular function. The increased cell metabolism and proliferation that results from this promote wound healing.

The term photobiomodulation refers to the impact of laser light on cells. The origin of this phenomenon is related closely to how laser light affects cell organelles and the metabolic reactions taken on inside of them. It is important to note that photobiomodulation encompasses a wider range of light sources than just coherent laser light.

Additionally, laser surgery for gingivectomy and tissue healing is used in dentistry. Lasers have the advantage of having lower sensitivity and pain perception than traditional methods. Reactive oxygen species become active when subjected to laser therapy. During the course of dental therapy, choosing the right laser intensity and exposure time is crucial.

Low-level infrared light is used in cold laser therapy, a typical low-level laser therapy, to treat patients. Additionally, using a laser to generate reactive oxygen species is a successful method of treating pulpal wounds and promoting the growth of reparative dentin.

Thus, owing to the aforementioned factors, the global cold laser therapy market is expected to grow at a CAGR rate value of 4.4% during the forecast period from 2023 to 2033.

What are the Key Opportunities for the Market Players?

Chronic illnesses like those related to the kidneys are linked to chronic pain. According to the WHO, noncommunicable diseases (NCDs), which include diabetes, chronic lung disease, heart disease, and cancer, account for 74% of all fatalities globally. Eighty-six percent of the 17 million people who passed away early, or before the age of 70, and more than three-quarters of all NCD deaths take place in low- and middle-income nations.

Because of this, emerging countries are regarded as promising locations for investment and potential customers for cold laser therapy technology.

Key players' main strategy is acquiring the product profiles of new competitors. Companies prefer to buy the  Research and Development (R&D) divisions of up-and-coming players in order to jointly develop innovative and novel technologies.

Companies have a lot of financial leverage available to them through mergers and acquisitions for product development and commercialization.

For instance, Colfax successfully acquired DJO Global, Inc., a renowned producer of cold laser technology, in February 2019.

Moreover, manufacturers of cold laser therapy have more opportunities as the number of skin disorders and lifestyle changes grow. Throughout the course of the forecast period, reimbursement programs in the majority of developed nations are anticipated to drive up demand for cold laser therapy equipment within these nations.

The opportunity for innovation is also provided through fast-track approvals for novel device innovations.

These factors cumulatively are set to provide traction toward the growth of the overall market, during the forecast period.

What are the Factors Restraining Demand for Cold Laser Therapy?

Because cold laser therapy is expensive when used for dermatology, pain management, or other procedures, people in low- and middle-income nations cannot afford it. Additionally, non-invasive therapies need a number of sessions to produce the desired results. Because of the overall high cost of the therapy as a result, the market's growth is anticipated to be constrained over the forecast period.

Additionally, significant product recalls in recent years have had an effect on the market and are predicted to restrain market expansion. The majority of recalls were categorized as Class II recalls, meaning that there is a plausible risk that using the product could result in serious health repercussions or even death.

Pivotal Health Solutions recalled Apollo (cold) Laser Desktop Control Units on March 9, 2016. The internal mounting kit on the control units did not comply with medical safety standards and was conductive, raising the danger of electric shock to the user and patient. As a result, the FDA classified this recall as a Class II recall. These products were developed prior to the Apollo product line being purchased by Pivotal Health Solutions.

The above-mentioned factors impact the global market in a restrictive manner and are thus expected to hinder the growth of the market throughout the forecast period.

Country-wise Insights

What Makes the USA a Large Market for Cold Laser Therapy?

The USA is set to hold a total market share of about 36.5% in 2023, within the global market.

Due to new technologies being introduced by Start-ups and other manufacturers of medical equipment, the sector is growing. As a result of the market's accessibility to a variety of novel technologies, doctors may treat patients more effectively, which benefits patients' health.

For instance, IRIDEX Corporation, a producer of ophthalmic laser-based medical products, introduced the improved MicroPulse P3 Device in February 2020. The device is intended to treat glaucoma, and the improvements made to it are anticipated to significantly lower intraocular pressure for glaucoma patients who do not require incisions.

These developments are driving the growth of the market within the country.

What is the Outlook of Germany in the Cold Laser Therapy Market?

Germany is set to hold a market share of nearly 6.4% in the global cold laser therapy market in 2023.

The cold laser therapy industry is growing as more individuals become aware of the numerous benefits of this treatment. Sales of cold laser therapy are increasing due to its application in pain relief, musculoskeletal disorders, and nerve regeneration. These technologies are being used more commonly in home healthcare settings to give patients pain or inflammatory response therapy.

Due to social media's increasing use, people of all ages are exhibiting observable concerns over transforming their appearance. Thus, due to the country's rising interest in aesthetic surgery, the market for cold laser therapy is rapidly growing in Germany.

How is the Market Expected to Grow in Japan?

Japan is set to hold a share of around 5.6% in the global market, in 2023.

Since its founding in 1979, the Japan Society for Laser Surgery and Medicine has campaigned for the responsible use of lasers and other light sources. Japan has a long and distinguished history of medical laser study and experimentation. The Koseirodosho, Japan's similarly rigorous analog of the FDA in the USA, has recognized the JSLSM's safety courses as a valid accreditation for medical laser users, researchers, and engineers thanks to the organization's dedication to excellence in safety protocols.

Thus, established safety protocols within the country have propelled innovation within the market, thus providing lucrative traction to the global cold laser therapy market, over the forecast period.

Category-wise Insights

Which Cold Laser Therapy Product is Driving Market Growth?

Continuous laser devices are set to lead the market with a share of around 55.6% in the global market, in 2023.

In order to assist reduce swelling and inflammation, the continuous laser energy stimulates the lymphatic system as well as blood flow. By preventing pain signals from reaching the brain, pulsed laser energy also has analgesic effects in the treatment area. Additionally, continuous laser devices can be scanned to provide tissue exposure time that produces a tissue effect similar to that of pulsed lasers, enhancing therapy effectiveness.

Which Technology for Cold Laser Therapy is Widely Adopted within the Global Market?

Single wavelength cold laser therapy devices are expected to hold a share of around 65.7% in the global market, in 2023.

Numerous biological responses, including the management of pain, the reduction of inflammation, the reduction of scar tissue, the increase in cell metabolism, the improvement of vascular activity, and the acceleration of healing, are made possible by increased ATP production and, consequently, greater cellular energy, which is done through stimulation of tissues that are subjected to the single wavelength cold laser therapy.

Owed to these advantages the segment holds a greater share within the global market.

What Application of Cold Laser Therapy is Largely in Focus Globally?

The dermatology segment is set to hold a global market share of around 35.7% in 2023.

Since cold laser therapy does not involve surgery, it is a non-invasive method. The following medical, dermatological, and aesthetic conditions can all be treated using laser therapy:

It focuses on dermatitis and pattern baldness as causes of hair loss, it removes moles, birthmarks, sunspots, warts, and more, and decreases wrinkles, fine lines, and dark circles. These benefits encourage the segment's expansion within the global market during the projected period.

Which End User Benefits the Most With the Sales of Cold Laser Therapy Globally?

The specialty clinics segment is set to hold a market share of around 42.9% in the global market in 2023.

The segment holds a larger market share owed to the presence of updated equipment within the specialty clinic settings, as well as the presence of skilled professionals to engage in the treatment process. Moreover, with appropriate reimbursements, as well as accessibility to treatment, the segment holds a larger share in terms of end user, within the global market.

Competitive Landscape

Manufacturers anticipate increasing their respective revenue shares by concentrating on developing novel Cold Laser Therapy technology with lower prices. The main techniques used by manufacturers to boost their income include new launches through intensive R&D for strengthening product portfolios.

Instances of key developmental strategies by the industry players in the cold laser therapy market are given below:

• Apira Science Inc. gained approval from the Korea Food and Drug Administration (KFDA), the FDA Thailand, the Egyptian Ministry of Health (MoHP), and the Singapore Health Sciences Authority (HSA), in January 2018 to deliver iGrow's proprietary low-level light treatment (LLLT) technology to these markets.
• B-Cure Laser released a handheld laser therapy device, B-Cure Laser, in the United Kingdom in March 2021, relieving chronic pain sufferers.

Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the cold laser therapy space, which are available in the full report.

Report Scope as per Cold Laser Therapy Industry Analysis

Attribute	Details
Forecast Period	2023 to 2033
Historical Data Available for	2016 to 2022
Market Analysis	USD million for Value
Key Regions Covered	North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa
Key Countries Covered	The USA, Canada, Brazil, Mexico, Argentina, The United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC Countries, North Africa, and South Africa
Key Market Segments Covered	Product, Technology, Application, End User, and Region
Key Companies Profiled	Apira Science Inc.; B-Cure laser Australia; Erchonia Corporation; Theralase Inc.; DJO Global, Inc. (Colfax Corporation); BTL Corporate; BioLight Technologies LLC; THOR Photomedicine Ltd; Irradia; PhotoMedex; Lexington International, LLC; MICROLIGHT Corporation; Apollo (Pivotal Health Care LLC)
Pricing	Available upon Request

Key Market Segments Covered in Cold Laser Therapy Industry Research

Product:

• Continuous Laser Devices
• Pulse Laser Devices
• Combination Laser Devices

Technology:

• Single Wavelength Cold Laser Therapy Devices
• Multiple Wavelength Cold Laser Therapy Devices

Application:

• Pain Management
• Arthritis
• Wound Healing
• Nerve Regeneration
• Dermatology
• Musculoskeletal
• Others

End User:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Homecare Settings

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

Frequently Asked Questions

What is the market size in 2023?

The market is valued at US$ 117.1 million in 2023.

How is the historical performance of the market?

From 2016 to 2022, the market registered a CAGR of 4%.

What will be the market value in 2033?

The market shall reach US$ 180.8 million in 2033.

What is the CAGR for the United States Market?

The United States will register a 7% CAGR until 2033.

What opportunities await the market players?

Expanding medical applications create growth opportunities for cold laser therapy.